Nuvalent Inc. Class A (NUVL) Live Share Price, Invest From India

Nuvalent Inc. Class A Stock Performance

as on July 15, 2026 at 2:15 pm IST

Day's Low
Day's High
$123.95
Day's Price Range
$123.98
$123.96
0.01%
Downside
0.02%
Upside
52 Week's Low
52 Week's High
$71.13
52-Week Price Range
$123.99
$123.96
42.62%
Downside
0.02%
Upside

Nuvalent Inc. Class A share price movements today

Previous Close: $123.94
Open: $123.96
Volume: 967.5K
Day's Low - High: $123.95 - $123.98
52 Week Low - High: $71.13 - $123.99

Nuvalent Inc. Class A Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Nuvalent Inc. Class A Stock Fundamentals & Key Indicators

Check Nuvalent Inc. Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Nuvalent Inc. Class A vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nuvalent Inc. Class A with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Nuvalent Inc. Class A	BUY	$-	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$38.8B	585.06%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$119.5B	135.83%	27.95	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$78.2B	26.26%	18.78	27.87%	0.48%

Analyst Recommendation on Nuvalent Inc. Class A Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Nuvalent Inc. Class A. Average target price of $125.12

Nuvalent Inc. Class A Share Price Target

Get share price movements and forecasts by analysts on Nuvalent Inc. Class A.

What analysts predicted

0.93%UPSIDE

Target Price

$125.12

Current Price

$123.96

Analyzed by

16 Analysts

Target

$125.12

Nuvalent Inc. Class A target price $125.12, a slight upside of 0.93% compared to current price of $123.96. According to 16 analysts rating.

Nuvalent Inc. Class A Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-38	-44	-57	-84	-74	-84	-99	-122	-118	-109
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Nuvalent Inc. Class A Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-11	-14	-46	-73	-126	-260	-425
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Nuvalent Inc. Class A

Funds	Holdings
Deerfield Management Co	22.05%
Paradigm Biocapital Advisors LP	6.81%
JPMorgan Chase & Co	3.95%
T. Rowe Price Associates, Inc.	2.63%
Woodline Partners LP	0.77%

See all

Nuvalent Inc. Class A News & Key Events

Insights on Nuvalent Inc. Class A

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 years, NUVL stock has moved up by 199.1%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 591.8% return, outperforming this stock by 392.7%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 380.3% return, outperforming this stock by 335.2%

About Nuvalent Inc. Class A

Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. It develops small molecules that have the potential to overcome resistance, minimize adverse events, and address brain metastases. It is advancing a robust pipeline with investigational candidates for ROS proto-oncogene 1 (ROS1)-positive, anaplastic lymphoma kinase (ALK)-positive, and human epidermal growth factor receptor 2 (HER2)-positive non-small cell lung cancer, and multiple discovery-stage research programs. Its product candidate, Zidesamtinib (NVL-520), is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC). NVL-520 is a novel ROS1-selective inhibitor. Its product candidate, Neladalkib (NVL-655), is being developed for patients with ALK-positive NSCLC. NVL-655 is a brain-penetrant ALK-selective inhibitor. Its product candidate, NVL-330, is a brain-penetrant HER2-selective inhibitor.

Organisation	Nuvalent Inc. Class A
E-voting on shares	Click here to vote

FAQs

What is Nuvalent Inc. Class A share price today?

Nuvalent Inc. Class A share price today is $123.96 as on July 15, 2026 at 8:45 am IST at the close of the market. Nuvalent Inc. Class A share today touched a day high of $123.98 and a low of $123.95.

What is the 52 week high and 52 week low for Nuvalent Inc. Class A share?

Nuvalent Inc. Class A share touched a 52 week high of $123.99 on July 14, 2026 and a 52 week low of $71.13 on August 8, 2025. Nuvalent Inc. Class A stock price today i.e. July 15, 2026 at 8:45 am IST is closed at $123.96,which is 0.02% down from its 52 week high and 74.27% up from its 52 week low.

How to invest in Nuvalent Inc. Class A Stock (NUVL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nuvalent Inc. Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nuvalent Inc. Class A Shares that will get you 0.0121 shares as per Nuvalent Inc. Class A share price of $123.96 per share as on July 15, 2026 at 8:45 am IST.

What is the minimum amount required to buy Nuvalent Inc. Class A Stock (NUVL) from India?

Indian investors can start investing in Nuvalent Inc. Class A (NUVL) shares with as little as ₹95.3775 or $1 (as of August 5, 2026 at 2:29 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.77 in Nuvalent Inc. Class A stock (as per the Rupee-Dollar exchange rate as on August 5, 2026 at 2:29 pm IST). Based on Nuvalent Inc. Class A share’s latest price of $123.96 as on July 15, 2026 at 8:45 am IST, you will get 0.0807 shares of Nuvalent Inc. Class A. Learn more about fractional shares .